Home
APLLTD.NS

Alembic Pharmaceuticals Limited

NSEHealthcare
₹827.55
+1.13%+₹9.25 today
₹0.00₹0.00
Ask Warren
Open
₹0.00
Prev close
₹818.30
Day range
₹0 – ₹0
52W range
₹635.8 – ₹1,044.8
Volume
1.4L
Avg vol (20D)
2.1L
Mkt cap
₹16,190.9Cr
P/E TTM
24.0×

Trade Alembic Pharmaceuticals Limited with Artha

Sign in to place orders, set alerts, and sync your watchlist.

Sign in to trade

Company Metrics

Revenue (ttm)₹7344.90 Cr
Net Income (ttm)₹0.00
Shares Out19.66 Cr
EPS (ttm)
Forward PE
Dividend
Ex-Dividend DateInvalid Date

Trading Metrics

Beta0.37

About APLLTD.NS

Alembic Pharmaceuticals Limited, an integrated pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products in India and internationally. The company provides products in various therapeutic areas, such as cardiology, orthopaedics, anti-diabetic, ophthalmology, gynaecology, nephrology, gastrology, urology, dermatology, anti-infective, cold and cough, and animal health; generics formulations in oral solids, oncology oral solids and injectables, general injectables and ophthalmic products, dermatology, and oral suspension; and active pharmaceutical ingredients. It also exports its products. Alembic Pharmaceuticals Limited was founded in 1907 and is headquartered in Vadodara, India.

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees0
Stock ExchangeNSE
Ticker SymbolAPLLTD.NS
APLLTD.NS · NSE
Financial Performance

In 2026, Alembic Pharmaceuticals Limited's revenue was ₹7344.90 Cr, an increase of +4.40% compared to the previous year. Earnings were ₹0.00, an increase of +29.20%.

Revenue (2026)
₹7344.90 Cr
+4.40% YoY
Earnings (2026)
₹0.00
+29.20% YoY
Year-over-Year Growth
Revenue
+4.40%
Earnings
+29.20%

News

Save watchlists across devicesSet price alerts that buzz your phoneConnect Zerodha for one-tap trades
Create free account

We use analytics cookies to understand how you use Artha and improve your experience. No data is sold to third parties.